skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Strategic industry insight

Contact us to get more information

Construct winning strategies that anticipate where value will lie. In Vivo’s in-depth analysis spans influential  deals, R&D, commercial and market access strategies. 

How it helps 

With In Vivo, you’ll benefit from:

  • Insight about the key players in the industry
  • In-depth coverage of company strategies
  • Expert analysis of deal making, R&D, commercial, market access and finance strategies and trends
  • Exclusive insider insight and thought leadership
  • Help with specific questions from our renowned Ask-the-Analyst™ service



How it works

Access mission-critical information via a simple-to-use interface. And if you need to need to find out more about developments or pharmaceutical industry trends to support presentations, proposals or business-critical decisions, you can access our worldwide network of expert analysts through our acclaimed Ask-the-Analyst™ service. 

Plus, you can identify threats and opportunities using our Execs on the Move feature, which tracks the company movements of senior executives.

What's included

Pharma Intelligence: latest

  • In Vivo, Medtech Insight, Pink Sheet, Scrip

    The Rise of Digital Tools eBook

    Rise of digital tools eBook

    Explore how digital technologies are being used to address the disruption of clinical trials for drugs and medical technology caused by COVID-19. Stay current with insights from industry leaders, information on guidance and regulation, and an examination of how the challenges of this global crisis and the industry’s response to it may soon usher in a new era in worldwide healthcare.

    Topic Coronavirus

  • In Vivo

    The Sensational Trumps Sense As UK Voters Show Appetite For "Brexit"

    The Sensational Trumps Sense As UK Voters Show Appetite For "Brexit"

    As night turned to day on June 24, it became clearer by the hour that the unthinkable had happened, and the UK’s long and acrimonious debate about its 43-year membership of the European Union had ended in a victory for the Leave group. The local health care products industries made their views clear some weeks ago, but today and in the months to come, they will have to confront a Plan B that was never in the plans.

    Topic Market Access Brexit

  • Pink Sheet, Scrip, In Vivo

    Gene Therapy eBook

    Gene Therapy eBook

    Keep up with advances in the critically important, emerging area of gene therapy. This transformative new category of medicines has the potential to treat more diseases – including complex and rare diseases – with longer-lasting effects than traditional medicines.

    Topic Research & Development Deals

  • In Vivo

    COVID-19: Global Perspective Infographic

    COVID-19 Global Perspective

    Your snapshot view of how the life sciences in nations around the globe are responding to the COVID-19 pandemic is now available. Register today to receive your free World Vision 360° infographic from In Vivo. 

    Topic Strategy Research & Development

  • In Vivo

    World Vision 360° Pack

    World_Vision_360

    Get a global perspective on the current state of the pharma and medtech industries with In Vivo’s World Vision 360° article pack. Access your free pack for essential insights into research and development, innovations, trends and strategies for markets around the world.

    Topic Research & Development Strategy

  • In Vivo

    COVID-19 Vaccine Expectations Are Ambitious Not Impossible

    invivo-COVID-19 Vaccine Expectations Are Ambitious Not Impossible

    Johan Van Hoof, global head of vaccines at Janssen, talks to In Vivo about the company’s platform, how it is approaching COVID-19 research and the impact of today’s global pandemic on the future of vaccine R&D.

    Topic Coronavirus Vaccines

  • In Vivo

    Virtual Clinical Trials Find Bigger Voice As COVID-19 Forces Pharma Rethink

    invivo-virtualclinicaltrials

    The use of virtual, real-time and at-home testing to provide clinical trials data has been steadily gaining the interest of the health care industry. COVID-19 has put this opportunity into sharper focus, says CNS trials technology developer Cambridge Cognition, which is now adding a voice option to its portfolio.

    Topic Coronavirus Clinical Trials

  • In Vivo

    How To Obtain Effective Relief When A Global Pandemic Disrupts Your Supply Chain

    effective-relief

    The COVID-19 pandemic is disrupting global supply chains and companies need effective tools to manage the related contract disputes. Sidley Austin partner Dorothee Schramm and senior associate Katie von der Weid, both specialized in international commercial disputes, provide tips to help companies manage the situation.

    Topic Coronavirus Business Strategies Deals

  • In Vivo

    Coronavirus-Driven Regulatory Changes Put Telehealth On The Map

    Coronavirus-Driven

    Adoption of telehealth services has skyrocketed during the coronavirus outbreak and US experts are expecting the trend to continue post-pandemic, fundamentally transforming health care.

    Topic Coronavirus Digital Health

  • In Vivo

    In Vivo's Rising Leaders List

    The Rising Leaders List

    In Vivo brings you another exclusive look into the future of biopharma, medtech and healthtech with our new article pack that features interviews with rising leaders and established executives, all sharing their insight. Download your free pack for a view of how today’s rising leaders are shaping the life sciences industries of tomorrow.

    Topic Leadership Medtech

  • In Vivo

    In Vivo's 30 Rising Leaders of 2020

    Rising Leaders of 2020

    Find out who is coming through the ranks of biopharma, medtech and healthtech organizations with In Vivo’s infographic, “30 Rising Leaders of 2020”. Your free infographic provides a snapshot view of the entrepreneurs and innovators who are moving their industries forward with creative thinking and new technologies.

    Topic Leadership Medtech

  • In Vivo

    COVID-19 Pandemic Accelerates Shift Toward Virtual Trials

    COVID-19 Pandemic Accelerates Shift Toward Virtual Trials

    As the global shut-down caused by the coronavirus pandemic continues, sponsors are rushing to adapt clinical trials that can move to partial or completely remote monitoring, allowing patients to remain in their homes but continue to participate in studies. And the outbreak may have another silver lining for the biopharma industry, a chance to rebuild its reputation.

    Topic Coronavirus

  • In Vivo

    Bacteria Are Blind To Politics

    Bacteria Are Blind To Politics

    Evan Loh, CEO of infectious disease drug developer Paratek Pharmaceuticals, explains why eliminating the DISARM ACT, which focused on finding solutions against antimicrobial resistance, from the new coronavirus aid package is a shortsighted move by US congress. 

    Topic Coronavirus

  • In Vivo

    Drug Distributors Mitigate Coronavirus

    Drug Distributors Mitigate Coronavirus

    For most patients, drug distributors – companies that provide, control and manage drug supplies – operate as an unseen but critical link in the supply chain. In the context of a global pandemic, however, drug distributors play an even bigger role in helping to ensure that pharmacies, health systems and ultimately patients have access to essential medicines.

    Topic Coronavirus

  • In Vivo

    FDA Emphasizes Clinical Trial Flexibility During Coronavirus Pandemic

    FDA Emphasizes Clinical Trial Flexibility During Coronavirus Pandemic

    FDA guidance updated in mid-April offered workarounds for trial sponsors attempting to conduct clinical studies in a time of travel limitations, staffing changes and heightened patient safety issues. For trials involving complex products and administration, such as cell and gene therapies, sponsors must determine whether modified protocols can still maintain trial integrity. If not, it may be time to press pause. 

    Topic Coronavirus FDA

Meet the team

Editor

William Looney

Editor, Executive Editor, In Vivo

USA

William Looney

William specializes in

  • Biopharma Pipeline Strategy
  • Biotech
  • Commercial Strategy
  • Market Access
  • Policy & Regulation

+40 year(s) experience

Editor

Cathy Kelly

Editor, Senior editor

Washington DC, USA

Cathy Kelly

Cathy specializes in

  • Policy & Regulation
  • Market Intelligence
  • Market Access
  • Pricing & Reimbursement

+39 year(s) experience

Management

Denise Peterson

Management, Editor In Chief, Pharma US

Washington DC, USA

Denise Peterson

Denise specializes in

  • Commercial Strategy
  • Policy & Regulation

+38 year(s) experience

Next steps

Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: